BIOMAT Database Logo BIOMAT Database Logo

Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers. 2006

Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
Department of Pathology, University of Colorado Health Sciences Center, Denver, CO 80045, USA.

Members of the p160 steroid receptor cofactor family, including AIB1 (Amplified in Breast Cancer 1) (also known as SRC-3/RAC3/ACTR/pCIP/TRAM-1), are of interest in endometrial carcinoma as they affect the function of estrogen (ER) and progesterone receptors (PR). Since it is feasible that alterations in the expression levels of coregulators can either augment ER activity or reduce the ability of PR to oppose ER action in endometrial cancers, our primary aim was to analyze expression of the AIB1 protein in endometrial carcinoma, carcinoma-associated complex atypical hyperplasia, and carcinoma-associated normal endometrium using immunohistochemistry and tissue microarrays. Expression of AIB1 was compared with other biomarkers and clinicopathologic parameters. We also tested AIB1 expression in non-carcinoma associated hyperplastic, normal secretory and proliferative endometrium to determine baseline AIB1 levels. In endometrial carcinoma, there is a higher expression of AIB1 compared to carcinoma-associated complex atypical hyperplasia (0.007) or carcinoma-associated normal endometrium (<0.001). AIB1 expression correlates with older age (P = 0.003), peri- or postmenopausal status (P = 0.002) and a higher grade of carcinomas (P = 0.04). There were no differences in the expression of additional steroid hormone receptor co-activators (SRC-1 and p300/CBP) and the co-repressor SMRT between histologic categories. AIB1 expression correlated with ER (r = 0.30, P = 0.006). The strongest correlation was between ER and PR-B isoform nuclear expression (r = 0.52, P < 0.0001). AIB1 levels were higher in non-carcinoma associated normal and hyperplastic endometrium compared to carcinoma-associated complex atypical hyperplasia and carcinoma-associated normal endometrium, and were the highest in normal secretory endometrium. In conclusion, high AIB1 expression in endometrial carcinoma is associated with parameters of poor prognosis. We propose that when AIB1 is overexpressed in endometrial carcinoma, ER action is augmented, leading to endometrial hyperplasia and progression to malignancy. Future studies correlating expression with response to hormonal therapy may be beneficial.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D004714 Endometrial Hyperplasia Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant. Atypical Endometrial Hyperplasia,Complex Endometrial Hyperplasia,Simple Endometrial Hyperplasia,Atypical Endometrial Hyperplasias,Complex Endometrial Hyperplasias,Endometrial Hyperplasia, Atypical,Endometrial Hyperplasia, Complex,Endometrial Hyperplasia, Simple,Endometrial Hyperplasias,Endometrial Hyperplasias, Atypical,Endometrial Hyperplasias, Complex,Endometrial Hyperplasias, Simple,Hyperplasia, Atypical Endometrial,Hyperplasia, Complex Endometrial,Hyperplasia, Endometrial,Hyperplasia, Simple Endometrial,Hyperplasias, Atypical Endometrial,Hyperplasias, Complex Endometrial,Hyperplasias, Endometrial,Hyperplasias, Simple Endometrial,Simple Endometrial Hyperplasias
D004717 Endometrium The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo. Endometria
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas.
March 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.
August 1997, Science (New York, N.Y.),
Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells.
November 2001, Breast cancer research and treatment,
Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
January 2010, Chemotherapy,
Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
Steroid Receptor Coactivator-1 Expression in Pheochromocytoma: Clinicopathologic Correlation and Potential Diagnostic Pitfall.
January 2020, Applied immunohistochemistry & molecular morphology : AIMM,
Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium.
June 2002, The Journal of clinical endocrinology and metabolism,
Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
Production and characterization of monoclonal antibodies to the steroid receptor coactivator AIB1.
June 1999, Hybridoma,
Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
July 1997, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome.
August 2002, Cancer,
Nicole N Balmer, and Jennifer K Richer, and Nicole S Spoelstra, and Kathleen C Torkko, and Pamela L Lyle, and Meenakshi Singh
Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features.
May 2018, BMC research notes,
Copied contents to your clipboard!